- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04231305
Antithrombotics and Complications in Skin Grafts
January 14, 2020 updated by: Lene Birk-Sørensen, Aalborg University Hospital
Complications in Skin Grafts When Continuing Antithrombotic Therapy Prior to Cutaneous Surgery Requiring Skin Grafting: an Observational Study
Patients who were referred to cutaneous surgery and needed full thickness or split skin grafting and using antitrombotic or non-antitrombotic therapies were observed.
Data on patient characteristics, diagnosis, location of surgery and surgery performed, antithrombotic medication and complications in skin grafts were collected.
Skin grafts were traced on a transparent film and areas of unhealed skin graft were marked
Study Overview
Status
Completed
Conditions
Detailed Description
Use of anticoagulants is common and practice regarding continuation or discontinuation of the medication peri-operatively for cutaneous surgery lacks evidence-based consensus.
Therefore, patients who were referred to cutaneous surgery and needed full thickness or split skin grafting and using antitrombotic or non-antitrombotic therapies were observed.
Data on patient characteristics, diagnosis, location of surgery and surgery performed, antithrombotic medication and complications in skin grafts were collected.
Skin grafts were traced on a transparent film and areas of unhealed skin graft were marked
Study Type
Observational
Enrollment (Actual)
172
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aalborg, Denmark, 9000
- Aalborg University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
A total of 172 patients (92 males and 80 females) having 187 skin grafts were included.
Avarage size of the skin grafts were 1278 mm2 ranging from 52mm2 to 14283mm2.
Skin grafts where the patients received no or paused antithrombotic treatment were 90 while 97 skin grafts belonged to patients in antithrombotic treatment
Description
Inclusion Criteria:
Patients referred to cutanous surgery with full thickness or split skin grafting. The excision should be performed on the levels of subcutis or perichondrium -
Exclusion Criteria:
Patients having a pacemaker, needed skin graft on bare bone and patients with an INR above 3.5
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Postoperative bleeding
Time Frame: 5-7 postoperative day
|
5-7 postoperative day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lene Birk-Sørensen, PhD, Aalborg University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2015
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
January 14, 2020
First Submitted That Met QC Criteria
January 14, 2020
First Posted (Actual)
January 18, 2020
Study Record Updates
Last Update Posted (Actual)
January 18, 2020
Last Update Submitted That Met QC Criteria
January 14, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 2019-29-12
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Graft Complications
-
University of ArizonaTerminatedSkin Graft Complications | PRP | Skin Graft (Allograft) Rejection | Skin Graft DetachmentUnited States
-
University of Southern CaliforniaRecruitingSkin Graft ComplicationsUnited States
-
Federico II UniversityRecruitingWounds and Injuries | Skin Graft Scar | Skin Graft ComplicationsItaly
-
Loma Linda UniversityWithdrawnSkin Graft Complications
-
First Affiliated Hospital, Sun Yat-Sen UniversityCompletedMorality | Skin Graft ComplicationsChina
-
Institute of Liver and Biliary Sciences, IndiaCompletedBiliary Complications | Graft Function, Delayed
-
Hobart W. HarrisVitruvian Medical Devices, Inc.Not yet recruiting
-
Edixomed LtdTerminatedNitric Oxide Generating Gel Dressing in Patients With Superficial Partial Thickness Wounds (ProNOx2)Superficial Partial Thickness Burn | Skin Graft; ComplicationsUnited Kingdom
-
University of British ColumbiaUnknownCicatrix | Scar | Keloid | Hypertrophic Scar | Skin Graft Scar | Skin Graft Complications | Donor Site ComplicationCanada
-
Centre hospitalier de l'Université de Montréal...Centre de Recherche du Centre Hospitalier de l'Université de MontréalUnknownGraft Failure | Complications Due to Coronary Artery Bypass GraftCanada